Capstone Investment Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,647
Closed -$50K 1102
2021
Q1
$50K Buy
+10,647
New +$50K ﹤0.01% 529